281 related articles for article (PubMed ID: 28369050)
21. PAX5/TEL acts as a transcriptional repressor causing down-modulation of CD19, enhances migration to CXCL12, and confers survival advantage in pre-BI cells.
Fazio G; Palmi C; Rolink A; Biondi A; Cazzaniga G
Cancer Res; 2008 Jan; 68(1):181-9. PubMed ID: 18172310
[TBL] [Abstract][Full Text] [Related]
22. A developmentally controlled competitive STAT5-PU.1 DNA binding mechanism regulates activity of the Ig κ E3' enhancer.
Hodawadekar S; Park K; Farrar MA; Atchison ML
J Immunol; 2012 Mar; 188(5):2276-84. PubMed ID: 22279106
[TBL] [Abstract][Full Text] [Related]
23. Regulatory phosphorylation of Ikaros by Bruton's tyrosine kinase.
Ma H; Qazi S; Ozer Z; Zhang J; Ishkhanian R; Uckun FM
PLoS One; 2013; 8(8):e71302. PubMed ID: 23977012
[TBL] [Abstract][Full Text] [Related]
24. Transcriptional deregulation of oncogenic myocyte enhancer factor 2C in T-cell acute lymphoblastic leukemia.
Nagel S; Venturini L; Meyer C; Kaufmann M; Scherr M; Drexler HG; Macleod RA
Leuk Lymphoma; 2011 Feb; 52(2):290-7. PubMed ID: 21261500
[TBL] [Abstract][Full Text] [Related]
25. Interferon regulatory factors 4 and 8 induce the expression of Ikaros and Aiolos to down-regulate pre-B-cell receptor and promote cell-cycle withdrawal in pre-B-cell development.
Ma S; Pathak S; Trinh L; Lu R
Blood; 2008 Feb; 111(3):1396-403. PubMed ID: 17971486
[TBL] [Abstract][Full Text] [Related]
26. Targeting STAT5 or STAT5-Regulated Pathways Suppresses Leukemogenesis of Ph+ Acute Lymphoblastic Leukemia.
Minieri V; De Dominici M; Porazzi P; Mariani SA; Spinelli O; Rambaldi A; Peterson LF; Porcu P; Nevalainen MT; Calabretta B
Cancer Res; 2018 Oct; 78(20):5793-5807. PubMed ID: 30154155
[TBL] [Abstract][Full Text] [Related]
27. Early B-cell factor 1 (EBF1) is critical for transcriptional control of SLAMF1 gene in human B cells.
Schwartz AM; Putlyaeva LV; Covich M; Klepikova AV; Akulich KA; Vorontsov IE; Korneev KV; Dmitriev SE; Polanovsky OL; Sidorenko SP; Kulakovskiy IV; Kuprash DV
Biochim Biophys Acta; 2016 Oct; 1859(10):1259-68. PubMed ID: 27424222
[TBL] [Abstract][Full Text] [Related]
28. STAT5 regulation of BCL10 parallels constitutive NFkappaB activation in lymphoid tumor cells.
Nagy ZS; LeBaron MJ; Ross JA; Mitra A; Rui H; Kirken RA
Mol Cancer; 2009 Aug; 8():67. PubMed ID: 19709433
[TBL] [Abstract][Full Text] [Related]
29. Regulation of B cell linker protein transcription by PU.1 and Spi-B in murine B cell acute lymphoblastic leukemia.
Xu LS; Sokalski KM; Hotke K; Christie DA; Zarnett O; Piskorz J; Thillainadesan G; Torchia J; DeKoter RP
J Immunol; 2012 Oct; 189(7):3347-54. PubMed ID: 22956576
[TBL] [Abstract][Full Text] [Related]
30. BACH2 mediates negative selection and p53-dependent tumor suppression at the pre-B cell receptor checkpoint.
Swaminathan S; Huang C; Geng H; Chen Z; Harvey R; Kang H; Ng C; Titz B; Hurtz C; Sadiyah MF; Nowak D; Thoennissen GB; Rand V; Graeber TG; Koeffler HP; Carroll WL; Willman CL; Hall AG; Igarashi K; Melnick A; Müschen M
Nat Med; 2013 Aug; 19(8):1014-22. PubMed ID: 23852341
[TBL] [Abstract][Full Text] [Related]
31. Regulation of Small GTPase Rab20 by Ikaros in B-Cell Acute Lymphoblastic Leukemia.
Payne JL; Song C; Ding Y; Dhanyamraju PK; Bamme Y; Schramm JW; Desai D; Sharma A; Gowda C; Dovat S
Int J Mol Sci; 2020 Mar; 21(5):. PubMed ID: 32138279
[TBL] [Abstract][Full Text] [Related]
32. Ikaros dominant negative isoform (Ik6) induces IL-3-independent survival of murine pro-B lymphocytes by activating JAK-STAT and up-regulating Bcl-xl levels.
Kano G; Morimoto A; Takanashi M; Hibi S; Sugimoto T; Inaba T; Yagi T; Imashuku S
Leuk Lymphoma; 2008 May; 49(5):965-73. PubMed ID: 18464116
[TBL] [Abstract][Full Text] [Related]
33. Disruption of IKAROS activity in primitive chronic-phase CML cells mimics myeloid disease progression.
Beer PA; Knapp DJ; Miller PH; Kannan N; Sloma I; Heel K; Babovic S; Bulaeva E; Rabu G; Terry J; Druker BJ; Loriaux MM; Loeb KR; Radich JP; Erber WN; Eaves CJ
Blood; 2015 Jan; 125(3):504-15. PubMed ID: 25370416
[TBL] [Abstract][Full Text] [Related]
34. Pathogenesis and regulation of cellular proliferation in acute lymphoblastic leukemia - the role of Ikaros.
Wang H; Ouyang H; Lai L; Petrovic-Dovat L; Stankov K; Bogdanovic G; Dovat S
J BUON; 2014; 19(1):22-8. PubMed ID: 24659638
[TBL] [Abstract][Full Text] [Related]
35. PU.1 cooperates with IRF4 and IRF8 to suppress pre-B-cell leukemia.
Pang SH; Minnich M; Gangatirkar P; Zheng Z; Ebert A; Song G; Dickins RA; Corcoran LM; Mullighan CG; Busslinger M; Huntington ND; Nutt SL; Carotta S
Leukemia; 2016 Jun; 30(6):1375-87. PubMed ID: 26932576
[TBL] [Abstract][Full Text] [Related]
36. Negative regulation of HIV-1 transcription by a heterodimeric NF-κB1/p50 and C-terminally truncated STAT5 complex.
Della Chiara G; Crotti A; Liboi E; Giacca M; Poli G; Lusic M
J Mol Biol; 2011 Jul; 410(5):933-43. PubMed ID: 21763497
[TBL] [Abstract][Full Text] [Related]
37. Mismatch repair and the downstream target genes, PAX5 and Ikaros, in childhood acute lymphoblastic leukemia.
Best A; Matheson E; Minto L; Hall AG; Irving JA
Leuk Res; 2010 Aug; 34(8):1098-102. PubMed ID: 20233627
[TBL] [Abstract][Full Text] [Related]
38. EBF1 and PAX5 control pro-B cell expansion via opposing regulation of the Myc gene.
Somasundaram R; Jensen CT; Tingvall-Gustafsson J; Åhsberg J; Okuyama K; Prasad M; Hagman JR; Wang X; Soneji S; Strid T; Ungerbäck J; Sigvardsson M
Blood; 2021 Jun; 137(22):3037-3049. PubMed ID: 33619557
[TBL] [Abstract][Full Text] [Related]
39. Transcriptional circuits in B cell transformation.
Hu Y; Yoshida T; Georgopoulos K
Curr Opin Hematol; 2017 Jul; 24(4):345-352. PubMed ID: 28463873
[TBL] [Abstract][Full Text] [Related]
40. Expression of B cell-associated transcription factors in B-cell precursor acute lymphoblastic leukemia cells: association with PU.1 expression, phenotype, and immunogenotype.
Nishii K; Kita K; Miwa H; Shikami M; Taniguchi M; Usui E; Katayama N; Shiku H
Int J Hematol; 2000 Jun; 71(4):372-8. PubMed ID: 10905058
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]